lansoprazole has been researched along with Osteoporosis in 3 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients receiving lansoprazole treatment had a reduced risk of osteoporosis as compared with those undergoing other PPI therapy (adjusted HR, 0." | 8.12 | Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study. ( Chen, YC; Chou, YC; Chung, MH; Hueng, DY; Lin, MH; Lin, TK; Sun, CA; Wu, WT; Yang, YJ, 2022) |
| "Patients receiving lansoprazole treatment had a reduced risk of osteoporosis as compared with those undergoing other PPI therapy (adjusted HR, 0." | 4.12 | Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study. ( Chen, YC; Chou, YC; Chung, MH; Hueng, DY; Lin, MH; Lin, TK; Sun, CA; Wu, WT; Yang, YJ, 2022) |
| "Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors." | 1.31 | Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z | 1 |
| Liu, Y | 2 |
| Ma, M | 1 |
| Sun, S | 1 |
| Ma, Z | 1 |
| Wang, Y | 2 |
| Yu, L | 1 |
| Qian, X | 1 |
| Sun, L | 1 |
| Zhang, X | 1 |
| Chung, MH | 3 |
| Chen, YC | 3 |
| Wu, WT | 3 |
| Lin, MH | 3 |
| Yang, YJ | 3 |
| Hueng, DY | 3 |
| Lin, TK | 3 |
| Chou, YC | 3 |
| Sun, CA | 3 |
| Prasad, R | 1 |
| De Silva, M | 1 |
3 other studies available for lansoprazole and Osteoporosis
| Article | Year |
|---|---|
Lansoprazole-induced osteoporosis via the IP3R- and SOCE-mediated calcium signaling pathways.
Topics: Animals; Calcium; Calcium Signaling; Lansoprazole; Mice; Mice, Inbred ICR; Osteoblasts; Osteoporosis | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study.
Topics: Cohort Studies; Female; Humans; Lansoprazole; Male; Osteoporosis; Proton Pump Inhibitors; Retrospect | 2022 |
Osteoporosis with underlying connective tissue disease: an unusual case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant | 2002 |